Guido H.
- Country
- Germany
- Department
- Clinic and Polyclinic for Radiation Therapy (“Klinik und Poliklinik für Strahlentherapie”)
Research Overview
- INDIE: Phase II Trial of Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma
- Phase III Evaluation of Xevinapant and Radiotherapy Versus Placebo and Radiotherapy in High-Risk Resected Squamous Cell Carcinoma of the Head and Neck
- Evaluation of Durvalumab in Combination with Cisplatin, Carboplatin, and Etoposide with Radiotherapy in Extensive-Stage Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 91 of 303 partner sites.
Specializations
Head and Neck Oncology
The investigator specializes in treating advanced head and neck squamous cell carcinoma, with particular focus on both resected and unresected cases. Their research encompasses innovative therapeutic approaches for locally advanced head and neck cancer, including post-surgical and non-surgical treatment pathways.
- Post-operative radiotherapy protocols
- Combined modality treatments
- Novel therapeutic agents in HNSCC
Gastrointestinal Oncology
The investigator focuses on treating complex gastrointestinal malignancies, particularly intermediate and high-risk rectal cancer and locally-advanced anal carcinoma. Their expertise includes organ preservation strategies and innovative radiochemotherapy approaches.
- Organ preservation protocols
- Combined modality treatments
- Selective therapeutic approaches
Hematologic Oncology
The investigator has significant expertise in treating lymphoid malignancies, specifically early-stage classical Hodgkin lymphoma and early stage follicular lymphoma. Their work includes implementing novel immunotherapy approaches and optimizing radiation therapy protocols.
- Immunotherapy integration
- PET-guided treatment strategies
- Targeted antibody therapies
Thoracic Oncology
The investigator specializes in treating extensive stage small cell lung cancer, developing comprehensive treatment approaches that combine various therapeutic modalities. Their work focuses on integrating immunotherapy with radiation-based treatments.
- Combined radiochemotherapy
- Stereotactic radiotherapy
- Immunotherapy combinations
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.